Hi Jason,
ACQ is an interesting one - it was struggling heading into the pandemic and then it was made worse by the pandemic. If you look at its chart - it is not a pretty one.
It has since rebounded of pandemic lows, to trade well beyond where it was pre-pandemic. In fact, it is now touching levels not seen since 2015. It was a value stock for a while and today, I'd consider it close to fully valued. It is trading at a 16 times forward earnings and around 2.8 times book value (well above historical average of 1.7 times BV). Revenue and earnings are expected to grow by the mid single digits and high teens in fiscal 2022, which is pretty decent and above historical averages.
Given its recent run, i'd be weary here. What makes this company worth more than it was pre-pandemic when revenue is only expected to surpass 2019 levels in Fiscal 2022? There is lots of opportunity for acquisitions which I do like, but historical performance makes me skeptical. Decent value and growth potential, questionable ability to deliver.
Mat